Expression of integrin αvβ3 in small blood vessels of glioblastoma tumors

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 11, 1996, Pages 1143-1149

  Gladson, Candece L ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adhesion; Angiogenesis; Glioblastoma; Integrin receptor v 3; Integrin receptor v 5

Indexed keywords

INTEGRIN;

ANGIOGENESIS; ARTICLE; ASTROCYTOMA; CELL ADHESION; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BLOOD FLOW; TUMOR GROWTH;

EID: 0029846478     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199611000-00005     Document Type: Article

References (50)

1. Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH, Cheresh DA. Antiintegrin alpha ν beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 1995;96(4): 1815-22
2. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA. Integrin alpha ν beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994;79(7):1157-64
3. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-34
4. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87
5. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA. Definition of two angiogenic pathways by distinct alpha ν integrins. Science 1995;270(5241):1500-1502
6. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alpha ν beta 3 for angiogenesis. Science 1994;264(5158): 569-71
7. Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25
8. Gladson CL, Cheresh DA. The αν Integrins. In: Takada Y, ed. Integrin: The biologic problem. 1st ed. Boca Raton, FL: CRC Press, 1994:83-99
9. Clark EA, Bruggae JS. Integrins and signal transduction pathways: The road taken. Science 1995;269:233-39
10. Busk M, Pytela R, Sheppard D. Characterization of the integrin ανβ6 as a fibronectin binding protein. J Biol Chem 1992;267:5790-96
11. Nishimura SL, Sheppard D, Pytela R. Integrin ανβ8. Interaction with vitronectin and functional divergence of the β8 cytoplasmic domain. J Biol Chem 1994;269:28708-15
12. Davis CM, Danehower SC, Laurenza A, Molony JL. Identification of a role of the vitronectin receptor and protein kinase C in the induction of endothelial cell vascular formation. J Cell Biochem 1993;51(2):206-18
13. Brem S. The role of vascular proliferation in the growth of brain tumors. Clin Neurosurg 1976;23:440-53
14. Brem S, Cotran R, Folkman J. Tumor angiogenesis: A quantitative method for histologic grading. J Natl Cancer Inst 1972;48:347-56
15. Wesseling P, van der Laak JA, de Leeuw H, Ruiter DJ, Burger PC. Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections. J Neurosurg 1994;81(6): 902-9
16. Wesseling P, Schlingermann RO, Rietveld FJ, Link M, Burger PC, Ruiter DJ. Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: An immuno-light and immuno-electron microscopic study. J Neuropath Exp Neurol 1995;54(3):304-10
17. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumors. Brain Pathol 1993;3:255-68
18. Paulus W, Baur I, Schuppan D, Roggendorf W. Characterization of integrin receptors in normal and neoplastic human brain. Am J Pathol 1993;143(1):154-63
19. Gingras MC, Roussel E, Bruner JM, Branch CD, Moser RP Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissue. J Neuroimmunol 1995;57(1-2):143-53
20. McGeer PL, Zhu SG, Dedhar S. Immunostaining of human brain capillaries by antibodies to very late antigens. J Neuroimmunol 1990;26:213-18
21. Previtali S, Quattrini A, Nemni R, Truci G, Ducati A, Wrabetz L, Canal N. α6β4 and α6β1 integrins in astrocytomas and other CNS tumors. J Neuropathol Exp Neurol 1996;55(4):456-65
22. Suzuki S, Argraves WS, Arai H, Languino LR, Pierschbacher MD, Ruoslahti E. Amino acid sequence of the vitronectin receptor α subunit and comparative expression of adhesion receptor mRNAs. J Biol Chem 1987;262:14080-85
23. Suzuki S, Argraves WS, Pytela R, Arai H, Krusius T, Pierschbacher MD, Ruoslahti E. cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. Proc Natl Acad Sci USA 1986;83:8614-18
24. Fitzgerald LA, Steiner B, Rail SC Jr, Lo S, Phillips DR. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. Identity with platelet glycoprotein IIIa and similarity to "integrin." J Biol Chem 1987;262:3936-39
25. McLean JW, Vestal DJ, Cheresh DA, Bodary SC. cDNA sequence of the human integrin β5 subunit. J Biol Chem 1990;265:17126-31
26. Ramasawamy H, Hemler ME. Cloning, primary structure and properties of a novel human integrin β subunit. EMBO J 1990;9:1561-68
27. Argraves WS, Suzuki S, Arai H, Thompson K, Pierschbacher MD, Ruoslahti E. Amino acid sequence of the human fibronectin receptor. J Cell Biol 1987;105:1183-90
28. Giancotti FG, Ruoslahti E. Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of chinese hamster ovary cells. Cell 1990;60:849-59
29. Gladson CL, Wilcox J, Saunders L, Gillespie GY, Cheresh DA. Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. J Cell Science 1995;108:947-56
30. Gladson CL, Pijuan-Thompson V, Olman MA, Gillespie GY, Yacoub IZ. Upregulation of urokinase and urokinase receptor genes in malignant astrocytomas. Am J Pathol 1995;146:1150-60
31. Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MR. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucl Acids Res 1984;12:7035-56
32. Cheresh DA, Spiro RA. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in melanoma cell attachment to vitronectin, fibrinogen and von Willebrand factor. J Biol Chem 1987;262:17703-11
33. Newman PJ, Kahn RA, Hines A. Detection and characterization of monoclonal antibodies to platelet membrane proteins. J Cell Biol 1981;90:249-53
34. Gladson CL, Cheresh DA. Glioblastoma expression of vitronectin and the ανβ3 integrin: Adhesion mechanism for transformed glial cells. J Clin Invest 1991;88:1924-32
35. Gladson CL, Hancock S, Arnold MM, Faye-Petersen OM, Castleberry R, Kelly D. Stage specific expression of integrin ανβ3 in neuroblastic tumors. Am J Pathol 1996;148(5):1423-34
36. Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M, Buck CA. Integrin distribution in malignant melanoma: Association of the beta 3 subunit with tumor progression. Cancer Res 1990;50:6757-64
37. Okada Y, Copeland BR, Hamann GF, Koziol JA, Cheresh DA, del Zoppo GJ. Integrin ανβ3 is expressed in selected microvessels following focal cerebral ischemia. Am J Pathol 1996. Forthcoming.
38. Sepp NT, Li LJ, Lee KH, Brown EJ, Caughman SW, Lawley TJ, Swerlick RA. Basic fibroblast growth factor increases expression of the alpha ν beta 3 complex on human microvascular endothelial cells. J Invest Dermal 1994;103(3):295-99
39. Klein S, Giancotti FG, Presta M, Albelda SM, Buck CA, Rifkin DB. Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol Biol Cell 1993;4(10):973-82
40. Hoshiga M, Alpers CE, Smith LL, Giachelli CM, Schwartz SM. Alpha-ν beta-3 integrin expression in normal and atherosclerotic artery. Cir Research 1995;77(6):1129-35
41. Zagzag D, Miller DC, Sato Y, Rifkin DB, Burstein DE. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res 1990;50:7393-98
42. Paulus W, Grothe C, Sensenbrenner M, Janet T, Baur I, Graf M, Roggendorf W. Localization of basic fibroblast growth factor, a mitogen and angiogenic factor, in human brain tumors. Acta Neuropathol 1990;79:418-23
43. Chung IY, Benveniste EN. Tumor necrosis factor production by astrocytes: Induction by lipopolysaccharide, interferon-gamma and interleukin-1. J Immunol 1990;144:2999-3005
44. McComb RD, Bigner DD. Immunohistochemical localization of monoclonal antibody-defined extracellular matrix antigens in human brain tumors. J Neuro-Oncology 1985;3:181-86
45. Zagzag D, Friedlander DR, Miller DC, et al. Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res 1995;55(4):907-14
46. Zagzag D, Friedlander DR, Doskik J, Chikramane S, Chan W, Greco MA, Allen JC, Dorovini-Zis K, Grumet M. Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Res 1996;56:182-89
47. Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994;265:1582-84
48. Bornstein P Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1. J Cell Biol 1995;130(3): 503-6
49. Sriramarao P, Mendier M, Bourdon MA. Endothelial cell attachment and spreading on human tenascin is mediated by α2α and ανβ3 integrins. J Cell Science 1993;105:1001-12
50. Joshi P, Chung CY, Aukhil I, Erickson HP. Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin. J Cell Science 1993;106:389-400